Risk of suicidality wasn't higher for type 2 diabetes patients starting on GLP-1 receptor agonists than for those on two other popular classes of diabetes drugs, a U.K. cohort study found. In fully ...
A shake for breakfast, a shake for lunch and a sensible dinner. That was SlimFast’s pitch to consumers in the 1980s and 1990s ...